JP2017505327A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505327A5
JP2017505327A5 JP2016550611A JP2016550611A JP2017505327A5 JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5 JP 2016550611 A JP2016550611 A JP 2016550611A JP 2016550611 A JP2016550611 A JP 2016550611A JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5
Authority
JP
Japan
Prior art keywords
oxy
pyridin
trifluoromethyl
alkyl
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6532474B2 (ja
JP2017505327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/014380 external-priority patent/WO2015119998A1/en
Publication of JP2017505327A publication Critical patent/JP2017505327A/ja
Publication of JP2017505327A5 publication Critical patent/JP2017505327A5/ja
Application granted granted Critical
Publication of JP6532474B2 publication Critical patent/JP6532474B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550611A 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用 Expired - Fee Related JP6532474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461936397P 2014-02-06 2014-02-06
US61/936,397 2014-02-06
PCT/US2015/014380 WO2015119998A1 (en) 2014-02-06 2015-02-04 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof

Publications (3)

Publication Number Publication Date
JP2017505327A JP2017505327A (ja) 2017-02-16
JP2017505327A5 true JP2017505327A5 (enExample) 2018-03-15
JP6532474B2 JP6532474B2 (ja) 2019-06-19

Family

ID=52484589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550611A Expired - Fee Related JP6532474B2 (ja) 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用

Country Status (14)

Country Link
US (3) US9452986B2 (enExample)
EP (1) EP3102569A1 (enExample)
JP (1) JP6532474B2 (enExample)
KR (1) KR20160118345A (enExample)
CN (1) CN106458985B (enExample)
AU (1) AU2015214366B2 (enExample)
BR (1) BR112016017996A2 (enExample)
CA (1) CA2938719A1 (enExample)
HK (1) HK1231471A1 (enExample)
IL (1) IL247014A0 (enExample)
MX (1) MX2016010056A (enExample)
RU (1) RU2016135637A (enExample)
SG (1) SG11201606367YA (enExample)
WO (1) WO2015119998A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
NZ722019A (en) 2014-01-13 2022-07-01 Aurigene Discovery Tech Ltd Bicyclic heterocyclyl derivatives as irak4 inhibitors
BR112016017996A2 (pt) * 2014-02-06 2017-08-08 Abbvie Inc 6-heteroariloxi- or 6-ariloxi-quinolina-2-carboxamidas e método de uso
MX2016017147A (es) * 2014-06-20 2017-06-07 Aurigene Discovery Tech Ltd Compuestos de indazole substituidos como inhibidores de irak4.
EP3191468B1 (en) * 2014-09-11 2018-12-12 Janssen Pharmaceutica NV Substituted 2-azabicycles and their use as orexin receptor modulators
EP3359151A4 (en) 2015-10-07 2019-08-14 Arizona Board of Regents on behalf of the University of Arizona CRMP2 SUMOYLATION INHIBITORS AND USES THEREOF
TWI720032B (zh) * 2015-10-09 2021-03-01 比利時商葛萊伯格有限公司 N-磺醯化吡唑并﹝3,4-b﹞吡啶-6-甲醯胺及其使用方法
BR112019012822A2 (pt) 2016-12-22 2019-11-26 Bayer Ag 1,2,4-tiadiazolilpirrolonas e 1,2,4-tiadiazolil-hidantoínas e sais das mesmas e uso das mesmas como herbicidas
IL305150B2 (en) 2017-03-31 2025-03-01 Aurigene Oncology Ltd Compounds and preparations for the treatment of hematological disorders
US11485733B2 (en) * 2017-06-30 2022-11-01 Bayer Animal Health Gmbh Azaquinoline derivatives
SI3704108T1 (sl) 2017-10-31 2024-07-31 Curis, Inc. Inhibitor irak4 v kombinaciji z inhibitorjem bcl-2 za uporabo pri zdravljenju raka
SG11202100137TA (en) 2018-07-09 2021-02-25 Lieber Institute Inc PYRIDAZINE COMPOUNDS FOR INHIBITING Nav1.8
US12234221B2 (en) 2018-07-09 2025-02-25 Lieber Institute, Inc. Pyridine carboxamide compounds for inhibiting NAV1.8
WO2020054657A1 (ja) 2018-09-10 2020-03-19 科研製薬株式会社 新規ヘテロ芳香族アミド誘導体及びそれを含有する医薬
CN113302175A (zh) 2018-11-09 2021-08-24 维瓦斯治疗公司 双环化合物
CA3126021A1 (en) * 2019-01-11 2020-07-16 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors
MX2021012638A (es) * 2019-04-16 2022-01-04 Vivace Therapeutics Inc Compuestos biciclicos.
EP4319750A4 (en) 2021-04-08 2025-02-26 Curis, Inc. COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
KR20240134944A (ko) * 2022-01-18 2024-09-10 쳉두 캉홍 파마슈티칼 코., 엘티디. 방향족 융합 고리 nav1.8 억제제 및 이의 용도
TW202434557A (zh) 2022-11-09 2024-09-01 瑞士商先正達農作物保護股份公司 殺微生物之吡唑衍生物
WO2025078263A1 (en) 2023-10-11 2025-04-17 Syngenta Crop Protection Ag Microbiocidal pyridyl pyrazole derivatives
WO2025233384A1 (en) 2024-05-08 2025-11-13 Syngenta Crop Protection Ag Microbiocidal pyrazole compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060118398A (ko) * 2003-08-05 2006-11-23 버텍스 파마슈티칼스 인코포레이티드 전압 개폐 이온 채널 억제제로서의 축합 피라미딘 화합물
EP1805166B1 (en) * 2004-10-19 2011-07-27 F. Hoffmann-La Roche AG Quinoline derivatives
EP1888558B1 (en) 2005-05-16 2011-10-05 Vertex Pharmaceuticals, Inc. Bicyclic derivatives as modulators of ion channels
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
BRPI0615613A2 (pt) * 2005-09-01 2009-05-19 Hoffmann La Roche diaminopirimidinas como moduladores de p2x3 e p3x2/3
TW200801012A (en) 2006-04-26 2008-01-01 Piramed Ltd Phosphoinositide 3-kinase inhibitor compounds and methods of use
CN103271906A (zh) * 2006-10-12 2013-09-04 泽农医药公司 螺-吲哚酮化合物作为治疗剂的用途
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
JP5685203B2 (ja) * 2009-05-29 2015-03-18 ラクオリア創薬株式会社 カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体
WO2011058766A1 (en) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Aryl carboxamide derivatives as ttx-s blockers
JP5807058B2 (ja) * 2010-05-10 2015-11-10 ギリアード サイエンシーズ, インコーポレイテッド 二機能キノリン誘導体
US9302991B2 (en) * 2010-10-18 2016-04-05 Raqualia Pharma Inc. Arylamide derivatives as TTX-S blockers
BR112015017997B1 (pt) * 2013-01-31 2023-03-07 Vertex Pharmaceuticals Incorporated Amidas de quinolina e quinoxalina como moduladores de canais de sódio, seus usos, e composição farmacêutica
BR112016017996A2 (pt) * 2014-02-06 2017-08-08 Abbvie Inc 6-heteroariloxi- or 6-ariloxi-quinolina-2-carboxamidas e método de uso

Similar Documents

Publication Publication Date Title
JP2017505327A5 (enExample)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
US10988478B1 (en) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
TWI879728B (zh) Shp2磷酸酶抑制劑及其使用方法
ES2548532T3 (es) Compuestos de pirrolopirimidina como inhibidores de CDK4/6
JP2014506929A5 (enExample)
AU2022325771A1 (en) Heterocyclic compounds and methods of use
AU2022265682A1 (en) 2-aminobenzothiazole compounds and methods of use thereof
AR119209A1 (es) DERIVADOS DE PIRROLO[1,2-c]IMIDAZOL COMO INHIBIDORES DE EGFR
JP2015526394A5 (enExample)
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2015537010A5 (enExample)
JP2015522002A5 (enExample)
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
JP2014534976A5 (enExample)
JP2018530557A5 (enExample)
JP2017524007A5 (enExample)
CN111655695B (zh) 作为pde1抑制剂的取代的呋喃并嘧啶化合物
JP2015533822A5 (enExample)
JP2019530739A5 (enExample)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
JPWO2020181283A5 (enExample)
KR20190088485A (ko) Gaba a 알파5 pam으로서 신규한 이소옥사졸릴 에터 유도체
JP2021504380A5 (enExample)
WO2024229317A1 (en) Spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof